Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Cerebral Amyloid Deposition With 18F-Flutemetamol PET and of Glucose Metabolism With 18F-FDG PET in Individuals Enrolled in the ALFA Project.

NCT02685969 is registered in ClinicalTrials.gov with Barcelonabeta Brain Research Center, Pasqual Maragall Foundation as lead sponsor.

NCT NCT02685969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02685969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Cerebral Amyloid Deposition With 18F-Flutemetamol PET and of Glucose Metabolism With 18F-FDG PET in Individuals Enrolled in the ALFA Project.
Lead sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2017
Completion date
December 31, 2027
Enrollment
570 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease